InspireMD
NSPR
4 hedge funds and large institutions have $248K invested in InspireMD in 2017 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.
0% less ownership
Funds ownership: 0% → 0% (-0%)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
20% less funds holding
Funds holding: 5 → 4 (-1)
40% less capital invested
Capital invested by funds: $416K → $248K (-$168K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VKH
Virtu KCG Holdings
New York
|
+$128K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$128K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$19K |
| 3 |
FPF
FNY Partners Fund
New York
|
-$3K |
NSPR Hedge Fund Activity: Q2 2017 in Review
4 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in InspireMD (NSPR) for Q2 2017, worth a combined $248K — down 40% from $416K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of NSPR and 0 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 1 added.
The largest buyer was Virtu KCG Holdings, adding an estimated $128K. The largest seller was Sabby Management, cutting an estimated $128K.
- 4 institutional investors held InspireMD (NSPR) as of Q2 2017, down from 5 in Q1 2017.
- Funds reported $248K of InspireMD stock for Q2 2017, down 40% quarter-over-quarter.
- 0 funds opened new InspireMD positions in Q2 2017 and 1 closed out, a net change of -1 holder.
- The largest InspireMD buyer in Q2 2017 was Virtu KCG Holdings, an estimated $128K added.
- The largest InspireMD seller in Q2 2017 was Sabby Management, an estimated $128K sold.
Based on aggregated 13F filings for Q2 2017.